<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-27365" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Pediatric Pneumonia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ebeledike</surname>
            <given-names>Chiemelie</given-names>
          </name>
          <aff>Advocate Christ Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ahmad</surname>
            <given-names>Thaer</given-names>
          </name>
          <aff>Advocate Christ Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Chiemelie Ebeledike declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Thaer Ahmad declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>16</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-27365.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Globally, pneumonia is a leading cause of morbidity and mortality in children younger than the age of 5. Although the majority of deaths attributed to pneumonia in children are mostly in the developing world, the burden of the disease is substantial, and there are significant healthcare-associated costs related to pneumonia in the developed world. This activity reviews the cause, pathophysiology, and presentation of pediatric pneumonia and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of pediatric pneumonia.</p></list-item><list-item><p>Review the presentation of pediatric pneumonia.</p></list-item><list-item><p>Outline the treatment and management options available for pediatric pneumonia.</p></list-item><list-item><p>Describe interprofessional team strategies for improving care coordination and outcomes in pediatric patients with pneumonia.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27365&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27365">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-27365.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Globally, pneumonia is a leading cause of morbidity and mortality in children younger than 5.<xref ref-type="bibr" rid="article-27365.r1">[1]</xref>&#x000a0;Although the majority of deaths attributed to pneumonia in children are mostly in the developing world, the burden of the disease is substantial, and there are significant healthcare-associated&#x000a0;costs related to pneumonia in the developed world.<xref ref-type="bibr" rid="article-27365.r2">[2]</xref></p>
      </sec>
      <sec id="article-27365.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of pneumonia in the pediatric population can be classified by age-specific versus pathogen-specific organisms.<xref ref-type="bibr" rid="article-27365.r3">[3]</xref>&#x000a0;Neonates are at risk for bacterial pathogens present in the birth canal, and this includes organisms such as group B streptococci, <italic toggle="yes">Klebsiella, Escherichia coli, and</italic>
<italic toggle="yes">Listeria monocytogenes</italic>.<xref ref-type="bibr" rid="article-27365.r4">[4]</xref><xref ref-type="bibr" rid="article-27365.r5">[5]</xref><xref ref-type="bibr" rid="article-27365.r6">[6]</xref>&#x000a0;<italic toggle="yes">Streptococcus pneumoniae, Streptococcus pyogenes, </italic>and<italic toggle="yes"> Staphylococcus aureus</italic> can be identified in late-onset neonatal pneumonia.<xref ref-type="bibr" rid="article-27365.r4">[4]</xref>&#x000a0;Viruses are the main cause of pneumonia in older infants and toddlers between 30 days and 2 years old.<xref ref-type="bibr" rid="article-27365.r7">[7]</xref>&#x000a0;In children 2 to 5 years old, respiratory viruses are also the most common.<xref ref-type="bibr" rid="article-27365.r8">[8]</xref><xref ref-type="bibr" rid="article-27365.r9">[9]</xref>&#x000a0;The rise of cases related to&#x000a0;<italic toggle="yes">S pneumoniae&#x000a0;and H influenzae </italic>type B&#x000a0;is observed in this age group.<xref ref-type="bibr" rid="article-27365.r10">[10]</xref><xref ref-type="bibr" rid="article-27365.r11">[11]</xref>&#x000a0;Mycoplasma pneumonia frequently occurs in children in the range of&#x000a0;5 to 13 years old<xref ref-type="bibr" rid="article-27365.r12">[12]</xref><xref ref-type="bibr" rid="article-27365.r13">[13]</xref>;&#x000a0;however, <italic toggle="yes">S pneumoniae</italic> is still the most commonly identified organism.<xref ref-type="bibr" rid="article-27365.r8">[8]</xref>&#x000a0;Adolescents usually have the same infectious risks as adults. It is important to consider tuberculosis (TB) in immigrants from high-prevalence areas and children with known exposures. Children with chronic diseases are also at risk for specific pathogens. In cystic fibrosis, pneumonia secondary to <italic toggle="yes">S aureus </italic>and<italic toggle="yes"> Pseudomonas aeruginosa</italic> is ubiquitous.<xref ref-type="bibr" rid="article-27365.r14">[14]</xref>&#x000a0;Patients with sickle cell disease are at risk of infection from encapsulated organisms.<xref ref-type="bibr" rid="article-27365.r15">[15]</xref>&#x000a0;Children who are immunocompromised should&#x000a0;be&#x000a0;evaluated for <italic toggle="yes">Pneumocystis jirovecii</italic>, cytomegalovirus, and fungal species if no other organism is identified.<xref ref-type="bibr" rid="article-27365.r16">[16]</xref>&#x000a0;Unvaccinated children are at risk for vaccine-preventable pathogens.</p>
      </sec>
      <sec id="article-27365.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>There are an estimated 120 million cases of pneumonia annually worldwide, resulting in as many as&#x000a0;1.3 million deaths.<xref ref-type="bibr" rid="article-27365.r3">[3]</xref>&#x000a0;Younger children under the age of 2 in the developing world account for nearly 80% of pediatric deaths secondary to pneumonia.<xref ref-type="bibr" rid="article-27365.r17">[17]</xref>&#x000a0;The prognosis of pneumonia is better in the developed world, with fewer lives claimed, but the burden of disease is extreme, with roughly 2.5 million cases yearly.&#x000a0;Approximately a third to half of these cases lead to hospitalizations.<xref ref-type="bibr" rid="article-27365.r18">[18]</xref>&#x000a0;The introduction of the pneumococcal vaccine has significantly lowered the risk of pneumonia in the United States.</p>
      </sec>
      <sec id="article-27365.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Pneumonia is an invasion of the lower respiratory tract below the larynx by pathogens either by inhalation, aspiration, respiratory epithelium invasion, or hematogenous spread.<xref ref-type="bibr" rid="article-27365.r19">[19]</xref>&#x000a0;There are barriers to infection that include anatomical structures (nasal hairs, turbinates, epiglottis, cilia) and humoral and cellular immunity.<xref ref-type="bibr" rid="article-27365.r19">[19]</xref>&#x000a0;Once these barriers are breached, infection, either by fomite/droplet spread (mostly viruses) or nasopharyngeal colonization (mostly bacterial), results in inflammation and injury or death of surrounding epithelium and alveoli. This is ultimately accompanied by a migration of inflammatory cells to the site of infection, causing an exudative process, which in turn&#x000a0;impairs oxygenation.<xref ref-type="bibr" rid="article-27365.r20">[20]</xref>&#x000a0;In the majority of cases, the microbe is not identified, and the most common cause is viral etiology.</p>
        <p>
<bold>There are 4 stages of lobar pneumonia:&#x000a0;</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>The first stage occurs within 24 hours and is characterized by alveolar edema and vascular congestion. Both bacteria and neutrophils are present.</p>
          </list-item>
          <list-item>
            <p>Red hepatization is the second stage, and it has the consistency of the liver. The stage is characterized by neutrophils, red blood cells, and desquamated epithelial cells. Fibrin deposits in the alveoli are common.</p>
          </list-item>
          <list-item>
            <p>The third stage of gray hepatization stage occurs 2 to 3 days later, and the lung appears dark brown. There is an accumulation of hemosiderin and hemolysis of red cells.</p>
          </list-item>
          <list-item>
            <p>The fourth stage is the resolution stage, where the cellula infiltrates is resorbed, and the pulmonary architecture is restored. If the healing is not ideal, then it may lead to parapneumonic effusions and pleural adhesions.</p>
          </list-item>
        </list>
        <p>In bronchopneumonia, there is often patch consolidation of one or more lobes. The neutrophilic infiltrate is chiefly around the center of the bronchi.</p>
      </sec>
      <sec id="article-27365.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>In many cases, complaints associated with pneumonia are nonspecific, including cough, fever, tachypnea, and difficulty breathing.<xref ref-type="bibr" rid="article-27365.r21">[21]</xref>&#x000a0;Young children may present with abdominal pain. Important history to obtain includes the duration of symptoms, exposures, travel, sick contacts, baseline health of the child, chronic diseases, recurrent symptoms, choking, immunization history, maternal health, or birth complications in neonates.<xref ref-type="bibr" rid="article-27365.r22">[22]</xref>&#x000a0;Physical exam should include observation for signs of respiratory distress, including tachypnea, nasal flaring, lower chest in-drawing, or hypoxia on room air.<xref ref-type="bibr" rid="article-27365.r21">[21]</xref>&#x000a0;</p>
        <p>Note that infants may present with a reported inability to tolerate feeds, with grunting or apnea. Auscultation for rales or rhonchi in all lung fields with the appropriately sized stethoscope can also aid in diagnosis. In the developed world, other adjuncts like laboratory testing and imaging can be a helpful part of the physical exam. No isolated physical exam finding can accurately diagnose pneumonia.<xref ref-type="bibr" rid="article-27365.r23">[23]</xref>&#x000a0;However, the combination of symptoms, including fever, tachypnea, focal crackles, and decreased breath sounds together, raises the sensitivity for finding pneumonia on x-ray.<xref ref-type="bibr" rid="article-27365.r23">[23]</xref>&#x000a0;Pneumonia is a clinical diagnosis that should take into consideration the history of present illness, physical exam findings, adjunct testing, and imaging modalities.</p>
      </sec>
      <sec id="article-27365.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Laboratory evaluation in children suspected of having pneumonia should ideally start with non-invasive, rapid bedside testing, including nasopharyngeal swab assays for influenza, respiratory syncytial virus, and human metapneumovirus when available and appropriate. This can help minimize unnecessary imaging and antibiotic treatment in children with influenza or bronchiolitis. Children who present with severe disease and appear toxic should have complete blood count (CBC), electrolytes, renal/hepatic function testing, and blood cultures performed.<xref ref-type="bibr" rid="article-27365.r24">[24]</xref>&#x000a0;These tests are generally not required in children who present with mild disease. Inflammatory markers do&#x000a0;not help distinguish between viral and bacterial pneumonia in the pediatric population.<xref ref-type="bibr" rid="article-27365.r24">[24]</xref><xref ref-type="bibr" rid="article-27365.r25">[25]</xref>&#x000a0;However, these tests may be obtained to trend disease progression and serve as prognostic indicators. Children who have been in areas endemic to tubercluosis, or have an exposure history, and present with signs and symptoms suspicious of pneumonia should have sputum samples or gastric aspirates collected for culture.</p>
        <p>Sputum Gram stain and culture are not productive as the samples are often contaminated by oral flora. Blood cultures can be done but are often negative. Today, serology is being used to determine the presence of mycoplasma, legionella, and chlamydia species. Polymerase chain reaction is becoming available in most hospitals, but still, the results take 24 to 48 hours. There are no clear guidelines for the routine use of chest x-ray in the pediatric population.<xref ref-type="bibr" rid="article-27365.r24">[24]</xref>&#x000a0;Although the chest x-ray can be helpful in the diagnosis and confirmation of pneumonia,<xref ref-type="bibr" rid="article-27365.r26">[26]</xref>&#x000a0;it carries with it risks, including radiation exposure, healthcare-associated costs, and false-negative results, increasing the use of unwarranted antibiotics. Imaging should be restricted to children who appear toxic, those with a&#x000a0;recurrent or prolonged course of illness despite treatment, and infants ages 0 to 3 months with a fever, suspected foreign body aspiration, or congenital lung malformation. Imaging can also&#x000a0;be considered in children younger than 5 years old who present with fever, leukocytosis, and no&#x000a0;identifiable source of infection.<xref ref-type="bibr" rid="article-27365.r26">[26]</xref>&#x000a0;Imaging may also be useful in those with acute worsening of upper respiratory infections or to rule out underlying mass in children who have "round pneumonia."<xref ref-type="bibr" rid="article-27365.r27">[27]</xref><xref ref-type="bibr" rid="article-27365.r28">[28]</xref></p>
      </sec>
      <sec id="article-27365.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment should be targeted to a specific pathogen that is suspected based on information obtained from history and physical exam. Supportive and symptomatic management is key and includes supplemental oxygen for hypoxia, antipyretics for fever, and fluids for dehydration. This is especially important for non-infectious pneumonitis and viral pneumonia for which antibiotics are not indicated.<xref ref-type="bibr" rid="article-27365.r21">[21]</xref><xref ref-type="bibr" rid="article-27365.r29">[29]</xref>&#x000a0;Cough suppressants&#x000a0;are not recommended.</p>
        <p>If bacterial pneumonia is suspected, treat empirically with antibiotics, keeping in mind significant history and bacterial pathogens that are&#x000a0;common to specific age groups. Neonates should receive ampicillin plus an aminoglycoside or third-generation cephalosporin;<xref ref-type="bibr" rid="article-27365.r21">[21]</xref><xref ref-type="bibr" rid="article-27365.r30">[30]</xref>&#x000a0;however, not ceftriaxone, as it can displace bound bilirubin and lead to kernicterus. Atypical pneumonia is common in infants 1 to 3 months old, and this group should have additional antibiotic coverage with erythromycin or clarithromycin.<xref ref-type="bibr" rid="article-27365.r21">[21]</xref><xref ref-type="bibr" rid="article-27365.r30">[30]</xref>&#x000a0;For infants and children over 3 months old, <italic toggle="yes">S pneumoniae</italic> is the most common, for which the drug of choice is high-dose oral amoxicillin or another beta-lactam antibiotic.<xref ref-type="bibr" rid="article-27365.r21">[21]</xref><xref ref-type="bibr" rid="article-27365.r30">[30]</xref>&#x000a0;In children older than 5, atypical agents have a more important role, and&#x000a0;macrolide antibiotics are usually first-line therapy.<xref ref-type="bibr" rid="article-27365.r21">[21]</xref></p>
        <p>Special attention should be given to children with chronic illnesses, as these might alter choices for antibiotics<xref ref-type="bibr" rid="article-27365.r21">[21]</xref>. Children with sickle cell anemia will need cefotaxime, macrolide, and vancomycin if severely ill. Children with cystic fibrosis will require piperacillin or ceftazidime plus tobramycin. Treat fulminant viral pneumonia as indicated, depending on the virus identified. For Varicella, use acyclovir, and for the respiratory syncytial virus (RSV), use ribavirin for high-risk patients. Patients with human immunodeficiency virus should be treated with sulfamethoxazole/trimethoprim and prednisone, and for cytomegalovirus, ganciclovir, and gamma globulin are the preferred agents. If methicillin-resistant&#x000a0;<italic toggle="yes">S aureus</italic>&#x000a0;(MRSA) is suspected, clindamycin or vancomycin may be given.</p>
        <p>It is important to have a high index of suspicion for complications, especially in patients returning for repeat evaluation. For patients sent home with symptomatic or supportive management for suspected viral pneumonia, consider a secondary bacterial infection or other diagnoses upon re-evaluation.<xref ref-type="bibr" rid="article-27365.r31">[31]</xref>&#x000a0;Children with uncomplicated bacterial infections who fail to respond to treatment within 72 hours should be assessed for complications, including pneumothorax, empyema, or pleural effusion.<xref ref-type="bibr" rid="article-27365.r32">[32]</xref>&#x000a0;Other systemic complications of pneumonia include sepsis, dehydration, arthritis, meningitis, and hemolytic uremic syndrome.</p>
        <p>Neonates and infants younger than 90 days old should be hospitalized for treatment, in addition to children who are immunocompromised or have other underlying chronic diseases like sickle cell anemia or cystic fibrosis.<xref ref-type="bibr" rid="article-27365.r21">[21]</xref>&#x000a0;Children with social factors that preclude access to care have failed outpatient therapy, or present with presumed tuberculosis should also be hospitalized.<xref ref-type="bibr" rid="article-27365.r33">[33]</xref>&#x000a0;Admission is often required for patients with respiratory distress and low oxygenation. In most cases, the presence of a parapneumonic effusion requires admission. Children with severe respiratory distress may require chest therapy or even mechanical ventilation. A large pleural effusion requires drainage for diagnostic and therapeutic purposes. In patients with empyema, early video-assisted thoracic surgery (VATS) correlates with decreased mortality, hospital stay, and ionizing radiation from CT scans. It is essential to ensure that clear discharge instructions and return precautions are given to parents or caregivers of children being discharged home in addition to close pediatrician follow-up.</p>
      </sec>
      <sec id="article-27365.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis for pediatric pneumonia includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Alveolar proteinosis</p>
          </list-item>
          <list-item>
            <p>Aortic stenosis</p>
          </list-item>
          <list-item>
            <p>Aseptic meningitis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Asphyxiating thoracic dystrophy&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Aspiration syndromes&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Asthma&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Atelectasis</p>
          </list-item>
          <list-item>
            <p>AV septal defect, complete&#x000a0;</p>
          </list-item>
          <list-item>
            <p>AV septal defect, unbalanced&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Bacteremia</p>
          </list-item>
          <list-item>
            <p>Birth trauma</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27365.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>For most children, the prognosis is good. Viral pneumonia tends to resolve without treatment. Long-term sequelae are rare. However, both staphylococcal and varicella pneumonia have guarded outcomes in children.&#x000a0;Children with tuberculosis are at high risk for disease progression if the condition is not treated. Immunocompromized children have the worst prognosis. Each year, roughly 3 million children die from pneumonia, and the majority of these children also have other comorbidities like congenital heart disease, immunosuppression, or chronic lung disease of prematurity.</p>
      </sec>
      <sec id="article-27365.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of pediatric pneumonia include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Empyema</p>
          </list-item>
          <list-item>
            <p>Pleural effusion</p>
          </list-item>
          <list-item>
            <p>Lung abscess</p>
          </list-item>
          <list-item>
            <p>Necrotizing pneumonia</p>
          </list-item>
          <list-item>
            <p>Sepsis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27365.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Pediatric pneumonia is often undertreated or missed, leading to high morbidity and mortality. The condition is best managed by an interprofessional team to improve outcomes. The majority of patients are managed by the pediatrician, nurse practitioner, or primary care provider.&#x000a0; Patient and caregiver education is vital. Parents need to be told to avoid smoking, and the importance of handwashing cannot be overstated. In addition, all clinicians looking after children should emphasize vaccination against pneumococcus and influenza.</p>
        <p>Healthcare professionals, including physicians, nurses, physician assistants, nurse practitioners, and pharmacists, ideally work together in close environments for optimum patient care. When caring for children with pneumonia, pharmacists can be of significant help with geographic resistance patterns for better treatment outcomes with selected antibiotic choices. Caregivers should be educated about signs of respiratory difficulty and when to seek medical assistance. Only through a team approach can pneumonia in children be treated promptly with minimal morbidity.</p>
      </sec>
      <sec id="article-27365.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27365&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27365">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/pediatric-pneumonia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=27365">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/27365/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=27365">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-27365.s14">
        <title>References</title>
        <ref id="article-27365.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>GR</given-names>
              </name>
            </person-group>
            <article-title>Tackling pneumonia and diarrhoea: the deadliest diseases for the world's poorest children.</article-title>
            <source>Lancet</source>
            <year>2012</year>
            <month>Jun</month>
            <day>09</day>
            <volume>379</volume>
            <issue>9832</issue>
            <fpage>2123</fpage>
            <page-range>2123-4</page-range>
            <pub-id pub-id-type="pmid">22682449</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rudan</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Nair</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Maru&#x00161;i&#x00107;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Reducing mortality from childhood pneumonia and diarrhoea: The leading priority is also the greatest opportunity.</article-title>
            <source>J Glob Health</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>010101</fpage>
            <pub-id pub-id-type="pmid">23826497</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rudan</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Nair</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Theodoratou</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Qazi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Luk&#x00161;i&#x00107;</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Fischer Walker</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Black</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>H</given-names>
              </name>
              <collab>Child Health Epidemiology Reference Group (CHERG)</collab>
            </person-group>
            <article-title>Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries.</article-title>
            <source>J Glob Health</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>010401</fpage>
            <pub-id pub-id-type="pmid">23826505</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arif</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Updated Recommendations Of Rcog On Prevention Of Early Onset Neonatal Group B Streptococcus Infection.</article-title>
            <source>J Ayub Med Coll Abbottabad</source>
            <year>2018</year>
            <season>Jul-Sep</season>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>490</fpage>
            <pub-id pub-id-type="pmid">30465394</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Jenkins-Marsh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Flenady</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ireland</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>May</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grimwood</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Liley</surname>
                <given-names>HG</given-names>
              </name>
            </person-group>
            <article-title>Early-onset group B streptococcal disease in a risk factor-based prevention setting: A 15-year population-based study.</article-title>
            <source>Aust N Z J Obstet Gynaecol</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>59</volume>
            <issue>3</issue>
            <fpage>422</fpage>
            <page-range>422-429</page-range>
            <pub-id pub-id-type="pmid">30203834</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al Hazzani</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Bawazeer</surname>
                <given-names>RAB</given-names>
              </name>
              <name>
                <surname>Shehata</surname>
                <given-names>AI</given-names>
              </name>
            </person-group>
            <article-title>Epidemiological characterization of serotype group B Streptococci neonatal infections associated with interleukin-6 level as a sensitive parameter for the early diagnosis.</article-title>
            <source>Saudi J Biol Sci</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>25</volume>
            <issue>7</issue>
            <fpage>1356</fpage>
            <page-range>1356-1364</page-range>
            <pub-id pub-id-type="pmid">30505181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verhoeven</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Influence of Immunological Maturity on Respiratory Syncytial Virus-Induced Morbidity in Young Children.</article-title>
            <source>Viral Immunol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>76</fpage>
            <page-range>76-83</page-range>
            <pub-id pub-id-type="pmid">30499759</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <collab>GBD 2016 Lower Respiratory Infections Collaborators</collab>
            <article-title>Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>18</volume>
            <issue>11</issue>
            <fpage>1191</fpage>
            <page-range>1191-1210</page-range>
            <pub-id pub-id-type="pmid">30243584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Omer</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Sutanto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sarwo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Linehan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Djelantik</surname>
                <given-names>IG</given-names>
              </name>
              <name>
                <surname>Mercer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Moniaga</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Moulton</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Widjaya</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Muljati</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gessner</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Steinhoff</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Climatic, temporal, and geographic characteristics of respiratory syncytial virus disease in a tropical island population.</article-title>
            <source>Epidemiol Infect</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>136</volume>
            <issue>10</issue>
            <fpage>1319</fpage>
            <page-range>1319-27</page-range>
            <pub-id pub-id-type="pmid">18177515</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gessner</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Sutanto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Linehan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Djelantik</surname>
                <given-names>IG</given-names>
              </name>
              <name>
                <surname>Fletcher</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gerudug</surname>
                <given-names>IK</given-names>
              </name>
              <name>
                <surname>Ingerani</surname>
              </name>
              <name>
                <surname>Mercer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Moniaga</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Moulton</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Moulton</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Mulholland</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Soemohardjo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Steinhoff</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Widjaya</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stoeckel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Maynard</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Arjoso</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial.</article-title>
            <source>Lancet</source>
            <year>2005</year>
            <month>Jan</month>
            <day>1-7</day>
            <volume>365</volume>
            <issue>9453</issue>
            <fpage>43</fpage>
            <page-range>43-52</page-range>
            <pub-id pub-id-type="pmid">15643700</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cutts</surname>
                <given-names>FT</given-names>
              </name>
              <name>
                <surname>Zaman</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Enwere</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Jaffar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>OS</given-names>
              </name>
              <name>
                <surname>Okoko</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Oluwalana</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vaughan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Obaro</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Leach</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McAdam</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Biney</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Saaka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Onwuchekwa</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Yallop</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pierce</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Greenwood</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Adegbola</surname>
                <given-names>RA</given-names>
              </name>
              <collab>Gambian Pneumococcal Vaccine Trial Group</collab>
            </person-group>
            <article-title>Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.</article-title>
            <source>Lancet</source>
            <string-date>2005 Mar 26-Apr 1</string-date>
            <volume>365</volume>
            <issue>9465</issue>
            <fpage>1139</fpage>
            <page-range>1139-46</page-range>
            <pub-id pub-id-type="pmid">15794968</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saraya</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title><italic>Mycoplasma pneumoniae</italic> infection: Basics.</article-title>
            <source>J Gen Fam Med</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>118</fpage>
            <page-range>118-125</page-range>
            <pub-id pub-id-type="pmid">29264006</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akashi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hayashi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shiigai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kanemoto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Notake</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ishiodori</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ishikawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Imai</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Clinical features and seasonal variations in the prevalence of macrolide-resistant <italic>Mycoplasma pneumoniae</italic>.</article-title>
            <source>J Gen Fam Med</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>191</fpage>
            <page-range>191-197</page-range>
            <pub-id pub-id-type="pmid">30464865</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dryahina</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sovov&#x000e1;</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nemec</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>&#x00160;pan&#x0011b;l</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Differentiation of pulmonary bacterial pathogens in cystic fibrosis by volatile metabolites emitted by their in vitro cultures: Pseudomonas aeruginosa, Staphylococcus aureus, Stenotrophomonas maltophilia and the Burkholderia cepacia complex.</article-title>
            <source>J Breath Res</source>
            <year>2016</year>
            <month>Aug</month>
            <day>10</day>
            <volume>10</volume>
            <issue>3</issue>
            <fpage>037102</fpage>
            <pub-id pub-id-type="pmid">27506232</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mart&#x000ed;-Carvajal</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Conterno</surname>
                <given-names>LO</given-names>
              </name>
            </person-group>
            <article-title>Antibiotics for treating community-acquired pneumonia in people with sickle cell disease.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2016</year>
            <month>Nov</month>
            <day>14</day>
            <volume>11</volume>
            <issue>11</issue>
            <fpage>CD005598</fpage>
            <pub-id pub-id-type="pmid">27841444</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stagno</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Brasfield</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Cassell</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Pifer</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Whitley</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Tiller</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: a prospective study.</article-title>
            <source>Pediatrics</source>
            <year>1981</year>
            <month>Sep</month>
            <volume>68</volume>
            <issue>3</issue>
            <fpage>322</fpage>
            <page-range>322-9</page-range>
            <pub-id pub-id-type="pmid">6269042</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garenne</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ronsmans</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>The magnitude of mortality from acute respiratory infections in children under 5 years in developing countries.</article-title>
            <source>World Health Stat Q</source>
            <year>1992</year>
            <volume>45</volume>
            <issue>2-3</issue>
            <fpage>180</fpage>
            <page-range>180-91</page-range>
            <pub-id pub-id-type="pmid">1462653</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Howie</surname>
                <given-names>SRC</given-names>
              </name>
              <name>
                <surname>Murdoch</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Global childhood pneumonia: the good news, the bad news, and the way ahead.</article-title>
            <source>Lancet Glob Health</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>e4</fpage>
            <page-range>e4-e5</page-range>
            <pub-id pub-id-type="pmid">30497987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bengoechea</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Sa Pessoa</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Klebsiella pneumoniae infection biology: living to counteract host defences.</article-title>
            <source>FEMS Microbiol Rev</source>
            <year>2019</year>
            <month>Mar</month>
            <day>01</day>
            <volume>43</volume>
            <issue>2</issue>
            <fpage>123</fpage>
            <page-range>123-144</page-range>
            <pub-id pub-id-type="pmid">30452654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zar</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Bacterial and viral pneumonia: New insights from the Drakenstein Child Health Study.</article-title>
            <source>Paediatr Respir Rev</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>24</volume>
            <fpage>8</fpage>
            <page-range>8-10</page-range>
            <pub-id pub-id-type="pmid">28687247</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jadavji</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Law</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lebel</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Gold</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>EE</given-names>
              </name>
            </person-group>
            <article-title>A practical guide for the diagnosis and treatment of pediatric pneumonia.</article-title>
            <source>CMAJ</source>
            <year>1997</year>
            <month>Mar</month>
            <day>01</day>
            <volume>156</volume>
            <issue>5</issue>
            <fpage>S703</fpage>
            <page-range>S703-11</page-range>
            <pub-id pub-id-type="pmid">9068582</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Don</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Risk factors of paediatric community-acquired pneumonia.</article-title>
            <source>Eur Respir J</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>724</fpage>
            <page-range>724-5; author reply 725</page-range>
            <pub-id pub-id-type="pmid">21357931</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neuman</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Monuteaux</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Scully</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Bachur</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Prediction of pneumonia in a pediatric emergency department.</article-title>
            <source>Pediatrics</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>128</volume>
            <issue>2</issue>
            <fpage>246</fpage>
            <page-range>246-53</page-range>
            <pub-id pub-id-type="pmid">21746723</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McIntosh</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Community-acquired pneumonia in children.</article-title>
            <source>N Engl J Med</source>
            <year>2002</year>
            <month>Feb</month>
            <day>07</day>
            <volume>346</volume>
            <issue>6</issue>
            <fpage>429</fpage>
            <page-range>429-37</page-range>
            <pub-id pub-id-type="pmid">11832532</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nohynek</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Valkeila</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Leinonen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eskola</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Erythrocyte sedimentation rate, white blood cell count and serum C-reactive protein in assessing etiologic diagnosis of acute lower respiratory infections in children.</article-title>
            <source>Pediatr Infect Dis J</source>
            <year>1995</year>
            <month>Jun</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>484</fpage>
            <page-range>484-90</page-range>
            <pub-id pub-id-type="pmid">7667052</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Markowitz</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Ruchelli</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Pneumonia in infants and children: radiological-pathological correlation.</article-title>
            <source>Semin Roentgenol</source>
            <year>1998</year>
            <month>Apr</month>
            <volume>33</volume>
            <issue>2</issue>
            <fpage>151</fpage>
            <page-range>151-62</page-range>
            <pub-id pub-id-type="pmid">9583110</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>YW</given-names>
              </name>
              <name>
                <surname>Donnelly</surname>
                <given-names>LF</given-names>
              </name>
            </person-group>
            <article-title>Round pneumonia: imaging findings in a large series of children.</article-title>
            <source>Pediatr Radiol</source>
            <year>2007</year>
            <month>Dec</month>
            <volume>37</volume>
            <issue>12</issue>
            <fpage>1235</fpage>
            <page-range>1235-40</page-range>
            <pub-id pub-id-type="pmid">17952428</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McLennan</surname>
                <given-names>MK</given-names>
              </name>
            </person-group>
            <article-title>Radiology rounds. Round pneumonia.</article-title>
            <source>Can Fam Physician</source>
            <year>1998</year>
            <month>Apr</month>
            <volume>44</volume>
            <fpage>751</fpage>
            <page-range>751, 757-9</page-range>
            <pub-id pub-id-type="pmid">9585845</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hall</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Powell</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Schnabel</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Gala</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Pincus</surname>
                <given-names>PH</given-names>
              </name>
            </person-group>
            <article-title>Risk of secondary bacterial infection in infants hospitalized with respiratory syncytial viral infection.</article-title>
            <source>J Pediatr</source>
            <year>1988</year>
            <month>Aug</month>
            <volume>113</volume>
            <issue>2</issue>
            <fpage>266</fpage>
            <page-range>266-71</page-range>
            <pub-id pub-id-type="pmid">3397789</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matera</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Rogliani</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ora</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cazzola</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Current pharmacotherapeutic options for pediatric lower respiratory tract infections with a focus on antimicrobial agents.</article-title>
            <source>Expert Opin Pharmacother</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>19</volume>
            <issue>18</issue>
            <fpage>2043</fpage>
            <page-range>2043-2053</page-range>
            <pub-id pub-id-type="pmid">30359143</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wald</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>Recurrent and nonresolving pneumonia in children.</article-title>
            <source>Semin Respir Infect</source>
            <year>1993</year>
            <month>Mar</month>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>46</fpage>
            <page-range>46-58</page-range>
            <pub-id pub-id-type="pmid">8372275</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Freij</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Kusmiesz</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>McCracken</surname>
                <given-names>GH</given-names>
              </name>
            </person-group>
            <article-title>Parapneumonic effusions and empyema in hospitalized children: a retrospective review of 227 cases.</article-title>
            <source>Pediatr Infect Dis</source>
            <year>1984</year>
            <season>Nov-Dec</season>
            <volume>3</volume>
            <issue>6</issue>
            <fpage>578</fpage>
            <page-range>578-91</page-range>
            <pub-id pub-id-type="pmid">6514596</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27365.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jain</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Arnold</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Ampofo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bramley</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Reed</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stockmann</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Grijalva</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Self</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hymas</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Chappell</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Kaufman</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Kan</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Dansie</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lenny</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hillyard</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Haynes</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lindstrom</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Winchell</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Erdman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hicks</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Wunderink</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Pavia</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>McCullers</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Finelli</surname>
                <given-names>L</given-names>
              </name>
              <collab>CDC EPIC Study Team</collab>
            </person-group>
            <article-title>Community-acquired pneumonia requiring hospitalization among U.S. children.</article-title>
            <source>N Engl J Med</source>
            <year>2015</year>
            <month>Feb</month>
            <day>26</day>
            <volume>372</volume>
            <issue>9</issue>
            <fpage>835</fpage>
            <page-range>835-45</page-range>
            <pub-id pub-id-type="pmid">25714161</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
